{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:10:02Z","timestamp":1791544202136,"version":"4.3.4"},"reference-count":276,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijbiomac.2025.145203","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T19:18:01Z","timestamp":1749669481000},"page":"145203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"P3","title":["Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A review"],"prefix":"10.1016","volume":"318","author":[{"given":"Cena","family":"Aram","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faezeh","family":"Firuzpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Barancheshmeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Javad","family":"Kamali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145203_bb0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0010","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.chom.2020.02.001","article-title":"Genome composition and divergence of the novel coronavirus (2019-nCoV) originating in China","volume":"27","author":"Wu","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0015","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0020","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0025","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1001\/jamainternmed.2020.3862","article-title":"Clinical course and molecular viral shedding among asymptomatic and symptomatic patients with SARS-CoV-2 infection in a community treatment center in the Republic of Korea","volume":"180","author":"Lee","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0030","series-title":"Coronavirus Cases: Deaths: Recovered","first-page":"1","author":"Pandemic","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/adhm.202001650","article-title":"siRNA therapeutics against respiratory viral infections\u2014what have we learned for potential COVID-19 therapies?","volume":"10","author":"Mehta","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0040","series-title":"Covid-19 variants tracker","first-page":"26","author":"GISAID","year":"2021"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0045","doi-asserted-by":"crossref","unstructured":"Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O'Connell, A.-M., Simons, D., Blomquist, P.B., Zaidi, A., Nash, S., Iwani Binti Abdul Aziz, N., Thelwall, S., Dabrera, G., Myers, R., Amirthalingam, G., Gharbia, S., Barrett, J.C., Elson, R., Ladhani, S.N., Ferguson, N., Zambon, M., Campbell, C.N.J., Brown, K., Hopkins, S., Chand, M., Ramsay, M., Lopez Bernal, J. Covid-19 vaccine effectiveness against the omicron (B.1.1.529) variant. N. Engl. J. Med. 0 (n.d.) null. https:\/\/doi.org\/10.1056\/NEJMoa2119451.","DOI":"10.1056\/NEJMoa2119451"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0050","doi-asserted-by":"crossref","first-page":"436.e1","DOI":"10.1016\/j.ajog.2023.12.022","article-title":"The association of post-embryo transfer SARS-CoV-2 infection with early pregnancy outcomes in in vitro fertilization: a prospective cohort study","volume":"230","author":"Li","year":"2024","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0055","article-title":"In silico design of siRNAs targeting existing and future respiratory viruses with VirusSi","author":"Zhang","year":"2020","journal-title":"BioRxiv Prepr. Serv. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0060","doi-asserted-by":"crossref","first-page":"7159","DOI":"10.1128\/JVI.77.13.7159-7165.2003","article-title":"Nucleic acid-based immune system: the antiviral potential of mammalian RNA silencing","volume":"77","author":"Gitlin","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0065","first-page":"47","article-title":"Traditional uses, chemistry and pharmacology of Ruscus genus (\u201cMurd esfarm\u201d in traditional Persian medicine); a review","volume":"4","author":"Shamalizade Baii","year":"2017","journal-title":"Res. J. Pharmacogn."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.contraception.2014.05.001","article-title":"Efficacy of fennel and combined oral contraceptive on depot medroxyprogesterone acetate-induced amenorrhea: a randomized placebo-controlled trial","volume":"90","author":"Mohebbi-Kian","year":"2014","journal-title":"Contraception"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0075","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10555-017-9717-6","article-title":"RNA interference-based therapy and its delivery systems","volume":"37","author":"Chen","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0080","doi-asserted-by":"crossref","first-page":"e1976","DOI":"10.1002\/rmv.1976","article-title":"A review on current status of antiviral siRNA","volume":"28","author":"Qureshi","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0085","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.3389\/fmicb.2018.02151","article-title":"RNA interference as a prospective tool for the control of human viral infections","volume":"9","author":"Levanova","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0090","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/978-1-4939-2291-8_25","article-title":"Computational design of artificial RNA molecules for gene regulation","volume":"1269","author":"Lagan\u00e0","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0095","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0014-5793(04)00087-0","article-title":"Silencing SARS-CoV spike protein expression in cultured cells by RNA interference","volume":"560","author":"Zhang","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0100","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1073\/pnas.0437841100","article-title":"RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription","volume":"100","author":"Ge","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0105","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1073\/pnas.252783999","article-title":"Interference of hepatitis C virus RNA replication by short interfering RNAs","volume":"100","author":"Kapadia","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0110","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.virusres.2004.01.010","article-title":"RNA silencing in viral infections: insights from poliovirus","volume":"102","author":"Saleh","year":"2004","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0115","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm725","article-title":"siRNA-directed inhibition of HIV-1 infection","volume":"8","author":"Novina","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0120","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(10)60357-1","article-title":"Postexposure protection of non-human primates against a lethal Ebola virus challenge with RNA interference: a proof-of-concept study","volume":"375","author":"Geisbert","year":"2010","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0125","article-title":"A small interfering RNA lead targeting RNA-dependent RNA-polymerase effectively inhibit the SARS-CoV-2 infection in Golden Syrian hamster and Rhesus macaque","author":"Gu","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0130","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1080\/14712598.2018.1472231","article-title":"siRNA drug development against hepatitis B virus infection","volume":"18","author":"Flisiak","year":"2018","journal-title":"Expert. Opin. Biol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.healun.2015.08.012","article-title":"ALN-RSV01 for prevention of bronchiolitis obliterans syndrome after respiratory syncytial virus infection in lung transplant recipients","volume":"35","author":"Gottlieb","year":"2016","journal-title":"J. Hear. Lung Transplant"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1001997","article-title":"For the RAPIDE-TKM trial team, experimental treatment of Ebola virus disease with TKM-130803: a single-arm phase 2 clinical trial","volume":"13","author":"Dunning","year":"2016","journal-title":"PLoS Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0145","doi-asserted-by":"crossref","first-page":"105815","DOI":"10.1016\/j.antiviral.2024.105815","article-title":"An intranasally delivered ultra-conserved siRNA prophylactically represses SARS-CoV-2 infection in the lung and nasal cavity","volume":"222","author":"Idris","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0150","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1111\/all.15663","article-title":"Treatment of COVID-19 patients with a SARS-CoV-2-specific siRNA-peptide dendrimer formulation","volume":"78","author":"Khaitov","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0155","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.7150\/ijbs.10452","article-title":"RNA interference (RNAi) induced gene silencing: a promising approach of hi-tech plant breeding","volume":"10","author":"Younis","year":"2014","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0160","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/MMBR.67.4.657-685.2003","article-title":"RNA interference: biology, mechanism, and applications","volume":"67","author":"Agrawal","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0165","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/molpharm.124.000895","article-title":"The growing class of novel RNAi therapeutics","volume":"106","author":"Traber","year":"2024","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0170","doi-asserted-by":"crossref","first-page":"114432","DOI":"10.1016\/j.bcp.2021.114432","article-title":"The growth of siRNA-based therapeutics: updated clinical studies","volume":"189","author":"Zhang","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0175","series-title":"RNA Interference in Caenorhabditis elegans \u2014 PMC","article-title":"Applications of RNAi in C. elegans research","author":"Cer\u00f3n","year":"2008"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0180","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/35078107","article-title":"Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells","volume":"411","author":"Elbashir","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0185","first-page":"52","article-title":"RNA silencing: a new therapeutic strategy against HIV","volume":"13","author":"Laurence","year":"2003","journal-title":"AIDS Read."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10123-020-00146-w","article-title":"RNA interference as a promising treatment against SARS-CoV-2","volume":"24","author":"Donia","year":"2021","journal-title":"Int. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0195","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nm828","article-title":"RNA interference targeting Fas protects mice from fulminant hepatitis","volume":"9","author":"Song","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0200","doi-asserted-by":"crossref","first-page":"7523","DOI":"10.1128\/JVI.78.14.7523-7527.2004","article-title":"Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells","volume":"78","author":"Wang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0205","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1348-0421.2005.tb03701.x","article-title":"Inhibitory effect of RNAi on Japanese encephalitis virus replication in vitro and in vivo","volume":"49","author":"Murakami","year":"2005","journal-title":"Microbiol. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0210","doi-asserted-by":"crossref","DOI":"10.3390\/v13102030","article-title":"Inhibition of SARS-CoV-2 replication by a small interfering RNA targeting the leader sequence","volume":"13","author":"Tolksdorf","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0215","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2180-8-47","article-title":"Aedes aegypti uses RNA interference in defense against Sindbis virus infection","volume":"8","author":"Campbell","year":"2008","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0220","doi-asserted-by":"crossref","DOI":"10.3791\/1292-v","article-title":"Virus-induced gene silencing (VIGS) in Nicotiana benthamiana and tomato","author":"Vel\u00e1squez","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0225","doi-asserted-by":"crossref","DOI":"10.3791\/2137-v","article-title":"RNAi screening for host factors involved in Vaccinia virus infection using Drosophila cells","author":"Moser","year":"2010","journal-title":"J. Vis. Exp."},{"issue":"2018","key":"10.1016\/j.ijbiomac.2025.145203_bb0230","article-title":"Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus","volume":"9","author":"Dhama","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0235","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1128\/JVI.01160-10","article-title":"Ebolavirus proteins suppress the effects of small interfering RNA by direct interaction with the mammalian RNA interference pathway","volume":"85","author":"Fabozzi","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0240","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41422-019-0152-9","article-title":"Zika virus infection induces RNAi-mediated antiviral immunity in human neural progenitors and brain organoids","volume":"29","author":"Xu","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0245","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fbioe.2020.00916","article-title":"Prospects for RNAi therapy of COVID-19","volume":"8","author":"Uluda\u011f","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0250","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.sjbs.2020.11.066","article-title":"In silico prediction and experimental validation of siRNAs targeting ORF1ab of MERS-CoV in Vero cell line","volume":"28","author":"Sohrab","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0255","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jiph.2020.12.018","article-title":"Designing and evaluation of MERS-CoV siRNAs in HEK-293 cell line","volume":"14","author":"Sohrab","year":"2021","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0260","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26092610","article-title":"In vitro inhibitory analysis of rationally designed siRNAs against MERS-CoV replication in Huh7 cells","volume":"26","author":"El-Kafrawy","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0265","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.7150\/ijbs.72706","article-title":"Development and application of ribonucleic acid therapy strategies against COVID-19","volume":"18","author":"Ning","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2023.105677","article-title":"Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2","volume":"217","author":"Bowden-Reid","year":"2023","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/v16071072","article-title":"Inhibition of SARS-CoV-2 replication by self-assembled siRNA nanoparticles targeting multiple highly conserved viral sequences","volume":"16","author":"Sun","year":"2024","journal-title":"Viruses"},{"issue":"2021","key":"10.1016\/j.ijbiomac.2025.145203_bb0280","article-title":"The potential therapeutic effect of RNA interference and natural products on COVID-19: a review of the coronaviruses infection","volume":"12","author":"Kalhori","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s13346-025-01815-x","article-title":"Preclinical testing of antiviral siRNA therapeutics delivered in lipid nanoparticles in animal models \u2014 a comprehensive review","author":"Idres","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0290","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1111\/j.1600-6143.2004.00530.x","article-title":"RNA interference: a potent tool for gene-specific therapeutics","volume":"4","author":"Ichim","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"2021","key":"10.1016\/j.ijbiomac.2025.145203_bb0295","article-title":"Nucleic acid-based treatments against COVID-19: potential efficacy of aptamers and siRNAs","volume":"12","author":"Khanali","year":"2021","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0300","article-title":"siRNA versus miRNA as therapeutics for gene silencing","volume":"4","author":"Lam","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0305","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","article-title":"Therapeutic siRNA: state of the art","volume":"5","author":"Hu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0310","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.addr.2010.03.008","article-title":"Engineering RNA for targeted siRNA delivery and medical application","volume":"62","author":"Guo","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0315","doi-asserted-by":"crossref","first-page":"elaf005","DOI":"10.1093\/bfgp\/elaf005","article-title":"Recent advances in investigation of circRNA\/lncRNA-miRNA-mRNA networks through RNA sequencing data analysis","volume":"24","author":"Gao","year":"2025","journal-title":"Brief. Funct. Genomics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0320","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13072-024-00560-8","article-title":"Crosstalk between non-coding RNAs and programmed cell death in colorectal cancer: implications for targeted therapy","volume":"18","author":"Taha","year":"2025","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0325","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/mp.2015.30","article-title":"Noncoding RNAs and neurobehavioral mechanisms in psychiatric disease","volume":"20","author":"Kocerha","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0330","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1186\/s12967-024-05554-4","article-title":"A systematic review of non-coding RNA therapeutics in early clinical trials: a new perspective against cancer","volume":"22","author":"Grillone","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0335","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.omtn.2017.06.005","article-title":"Therapeutic miRNA and siRNA: moving from bench to clinic as next generation medicine","volume":"8","author":"Chakraborty","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0340","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s12551-017-0392-1","article-title":"Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer","volume":"10","author":"Ahmadzada","year":"2018","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0345","doi-asserted-by":"crossref","first-page":"63","DOI":"10.14356\/kona.2016014","article-title":"Aerosol delivery of siRNA to the lungs. Part 1: rationale for gene delivery systems","volume":"33","author":"Youngren-Ortiz","year":"2016","journal-title":"Kona Powder Part. J."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0350","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14112520","article-title":"siRNA functionalized lipid nanoparticles (LNPs) in management of diseases","volume":"14","author":"Kalita","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0355","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12929-023-00981-9","article-title":"Small interfering RNA (siRNA)-based therapeutic applications against viruses: principles, potential, and challenges","volume":"30","author":"Kang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0360","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41392-023-01561-x","article-title":"Circular RNA vaccine in disease prevention and treatment","volume":"8","author":"Niu","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0365","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.3389\/fimmu.2018.03138","article-title":"The opening of Pandora\u2019s box: an emerging role of long noncoding RNA in viral infections","volume":"9","author":"Wang","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0370","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41573-021-00219-z","article-title":"Noncoding RNA therapeutics \u2014 challenges and potential solutions","volume":"20","author":"Winkle","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/v12121374","article-title":"Non-coding RNAs and SARS-related coronaviruses","volume":"12","author":"Henzinger","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0380","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.virol.2023.02.011","article-title":"Genetic conservation across SARS-CoV-2 non-structural proteins \u2014 insights into possible targets for treatment of future viral outbreaks","volume":"581","author":"Kandwal","year":"2023","journal-title":"Virology"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0385","doi-asserted-by":"crossref","first-page":"165878","DOI":"10.1016\/j.bbadis.2020.165878","article-title":"Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: structural genomics approach","volume":"1866","author":"Naqvi","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0390","doi-asserted-by":"crossref","DOI":"10.3390\/v14020385","article-title":"In silico prediction and selection of target sequences in the SARS-CoV-2 RNA genome for an antiviral attack","volume":"14","author":"Hussein","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0395","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cell.2020.12.006","article-title":"Genome-scale identification of SARS-CoV-2 and Pan-coronavirus host factor networks","volume":"184","author":"Schneider","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0400","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1038\/s41467-023-41788-4","article-title":"Systematic functional interrogation of SARS-CoV-2 host factors using Perturb-seq","volume":"14","author":"Sunshine","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0405","doi-asserted-by":"crossref","first-page":"107691","DOI":"10.1016\/j.micpath.2025.107691","article-title":"Decoding virulence and resistance in Klebsiella pneumoniae: pharmacological insights, immunological dynamics, and in silico therapeutic strategies","author":"Alishvandi","year":"2025","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0410","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2105-10-392","article-title":"siDirect 2.0: updated software for designing functional siRNA with reduced seed-dependent off-target effect","volume":"10","author":"Naito","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0415","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s43141-022-00346-z","article-title":"Design of siRNA molecules for silencing of membrane glycoprotein, nucleocapsid phosphoprotein, and surface glycoprotein genes of SARS-CoV2","volume":"20","author":"Ayyagari","year":"2022","journal-title":"J. Genet. Eng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0420","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/1479-5876-11-305","article-title":"VIRsiRNApred: a web server for predicting inhibition efficacy of siRNAs targeting human viruses","volume":"11","author":"Qureshi","year":"2013","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0425","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1093\/nar\/gni026","article-title":"SiRNA target site secondary structure predictions using local stable substructures","volume":"33","author":"Heale","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0430","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1016\/j.csbj.2025.03.034","article-title":"In silico and in vitro development of novel small interfering RNAs (siRNAs) to inhibit SARS-CoV-2","volume":"27","author":"Taibe","year":"2025","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0435","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1186\/s12951-023-02147-z","article-title":"Engineering siRNA therapeutics: challenges and strategies","volume":"21","author":"Ali Zaidi","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0440","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/oli.2008.0164","article-title":"Chemical modification of siRNAs for in vivo use","volume":"18","author":"Behlke","year":"2008","journal-title":"Oligonucleotides"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0445","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16111366","article-title":"The impact of COVID-19 on RNA therapeutics: a surge in lipid nanoparticles and alternative delivery systems","volume":"16","author":"Parvin","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0450","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2024.08.030","article-title":"Enhancing RNA-lipid nanoparticle delivery: organ- and cell-specificity and barcoding strategies","volume":"375","author":"Wei","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0455","doi-asserted-by":"crossref","first-page":"114416","DOI":"10.1016\/j.addr.2022.114416","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald Albertsen","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0460","article-title":"Nanoparticle delivery platforms for RNAi therapeutics targeting COVID-19 disease in the respiratory tract","volume":"23","author":"Zhang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0465","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jmii.2023.02.010","article-title":"Prophylactic intranasal administration of lipid nanoparticle formulated siRNAs reduce SARS-CoV-2 and RSV lung infection","volume":"56","author":"Supramaniam","year":"2023","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0470","doi-asserted-by":"crossref","first-page":"5886","DOI":"10.1016\/j.biomaterials.2010.03.075","article-title":"Virus-mimetic polymeric micelles for targeted siRNA delivery","volume":"31","author":"Xiong","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0475","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.801870","article-title":"Selection and validation of siRNAs preventing uptake and replication of SARS-CoV-2","volume":"10","author":"Friedrich","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0480","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.jconrel.2022.03.051","article-title":"Inhibition of SARS-CoV-2 replication in the lung with siRNA\/VIPER polyplexes","volume":"345","author":"Baldassi","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0485","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1099\/jgv.0.001453","article-title":"SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology","volume":"101","author":"Ogando","year":"2020","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0490","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/978-1-59745-191-8_11","article-title":"Application of siRNA against SARS in the rhesus macaque model","volume":"442","author":"Tang","year":"2008","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0495","doi-asserted-by":"crossref","first-page":"eadh7668","DOI":"10.1126\/scitranslmed.adh7668","article-title":"USP2 inhibition prevents infection with ACE2-dependent coronaviruses in vitro and is protective against SARS-CoV-2 in mice","volume":"15","author":"Dang","year":"2023","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0500","doi-asserted-by":"crossref","first-page":"e15298","DOI":"10.15252\/emmm.202115298","article-title":"A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant","volume":"14","author":"Chang","year":"2022","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0505","unstructured":"Khaitov M. R. Nikonova A. A. Kofiadi I. A. Shilovskiy I. P. Smirnov V. V Elisyutina O. G. Gudima G. O. Maerle A. V Shatilov A. A. Shatilova A. V Results of Clinical Trials Phases I and II of MIR 19\u00ae n.d."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0510","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15041106","article-title":"Dendrimer-mediated delivery of DNA and RNA vaccines","volume":"15","author":"Kisakova","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0515","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","article-title":"RNAi-based drug design: considerations and future directions","volume":"23","author":"Tang","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15020323","article-title":"Inclisiran-safety and effectiveness of small interfering RNA in inhibition of PCSK-9","volume":"15","author":"Wo\u0142owiec","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1009576","article-title":"DC\/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist","volume":"17","author":"Th\u00e9paut","year":"2021","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0530","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","volume":"26","author":"Sungnak","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0535","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"116","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0540","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0545","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0550","article-title":"The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes","author":"Feng","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0555","article-title":"Human kidney is a target for novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection","author":"Diao","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0560","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0959-437X(02)00290-3","article-title":"RNAi: nature abhors a double-strand","volume":"12","author":"Hutv\u00e1gner","year":"2002","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0565","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0092-8674(03)00801-8","article-title":"Functional siRNAs and miRNAs exhibit strand bias","volume":"115","author":"Khvorova","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0570","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/nrd1345","article-title":"siRNAs: applications in functional genomics and potential as therapeutics","volume":"3","author":"Dorsett","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0575","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(04)00258-2","article-title":"A Dicer-2-dependent 80s complex cleaves targeted mRNAs during RNAi in Drosophila","volume":"117","author":"Pham","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0580","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1126\/science.1069132","article-title":"RNA-dependent RNA polymerases, viruses, and RNA silencing","volume":"296","author":"Ahlquist","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0585","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature02873","article-title":"Mechanisms of gene silencing by double-stranded RNA","volume":"431","author":"Meister","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0590","doi-asserted-by":"crossref","first-page":"6620","DOI":"10.1039\/C6TB01462C","article-title":"Nanoparticle delivery systems for siRNA-based therapeutics","volume":"4","author":"Li","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.61186\/ist.202502.02.01","article-title":"Assessing physician confidence in artificial intelligence: insights from Iran","volume":"2","author":"Firuzpour","year":"2025","journal-title":"Infosci. Trends"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0600","doi-asserted-by":"crossref","first-page":"10271","DOI":"10.1038\/s41598-021-89605-6","article-title":"In silico analysis suggests the RNAi-enhancing antibiotic enoxacin as a potential inhibitor of SARS-CoV-2 infection","volume":"11","author":"Ahmadi","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0605","doi-asserted-by":"crossref","first-page":"6877","DOI":"10.1093\/emboj\/20.23.6877","article-title":"Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate","volume":"20","author":"Elbashir","year":"2001","journal-title":"EMBO J."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0610","first-page":"104951","article-title":"Designing an effective therapeutic siRNA to silence RdRp gene of SARS-CoV-2","volume":"93","author":"Shawan","year":"2021","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evol. Genet. Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0615","doi-asserted-by":"crossref","first-page":"8849","DOI":"10.1038\/s41598-021-88310-8","article-title":"A small interfering RNA (siRNA) database for SARS-CoV-2","volume":"11","author":"Medeiros","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0620","first-page":"1","article-title":"Sphingomyelin inhibits hydrolytic activity of heterodimeric PLA2 in model myelin membranes: pharmacological relevance","author":"Chaudary","year":"2024","journal-title":"J. Membr. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0625","doi-asserted-by":"crossref","first-page":"100574","DOI":"10.1016\/j.obmed.2024.100574","article-title":"Comparative analysis of fennel essential oil and manganese in PCOS rat model via modulating miR-145 expression and structure-based virtual screening of IGF2R protein to address insulin resistance and obesity","volume":"53","author":"Barancheshmeh","year":"2025","journal-title":"Obes. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0630","series-title":"Severe Acute Respiratory Syndrome","first-page":"465","author":"Loeb","year":"2006"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0635","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1385\/MB:33:2:141","article-title":"Identification of effective siRNA blocking the expression of SARS viral envelope E and RDRP genes","volume":"33","author":"Meng","year":"2006","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0640","doi-asserted-by":"crossref","first-page":"3917","DOI":"10.1038\/s41467-021-22785-x","article-title":"The architecture of the SARS-CoV-2 RNA genome inside virion","volume":"12","author":"Cao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0645","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.ymthe.2021.05.004","article-title":"A SARS-CoV-2 targeted siRNA-nanoparticle therapy for COVID-19","volume":"29","author":"Idris","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0650","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.242594499","article-title":"Retroviral delivery of small interfering RNA into primary cells","volume":"99","author":"Barton","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0655","unstructured":"Chang Y.-C. Yang C.-F. Chen Y.-F. Yang C.-C. Chou Y.-L. Chou H.-W. Chang T.-Y. Chao T.-L. Hsu S.-C. Ieong S.-M. Tsai Y.-M. Liu P.-C. Chin Y.-F. Fang J.-T. Kao H.-C. Lu H.-Y. Chang J.-Y. Weng R.-S. Tu Q.-W. Chang F.-Y. Huang K.-Y. Lee T.-Y. Chang S.-Y. Yang P.-C. A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant EMBO Mol. Med. e15298 10.15252\/emmm.202115298."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0660","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.3390\/molecules15107197","article-title":"Small interfering RNA effectively inhibits the expression of SARS coronavirus membrane gene at two novel targeting sites","volume":"15","author":"Wang","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0665","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1016\/j.febslet.2005.02.080","article-title":"Small interfering RNA inhibits SARS-CoV nucleocapsid gene expression in cultured cells and mouse muscles","volume":"579","author":"Zhao","year":"2005","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0670","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/sj.cr.7290286","article-title":"Inhibition of genes expression of SARS coronavirus by synthetic small interfering RNAs","volume":"15","author":"Shi","year":"2005","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0675","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1186\/s12879-024-10043-6","article-title":"Meningitis after COVID-19 vaccination, a systematic review of case reports and case series","volume":"24","author":"Atefi","year":"2024","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0680","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2004.09.005","article-title":"Inhibition of SARS-CoV replication by siRNA","volume":"65","author":"Wu","year":"2005","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0685","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.bbrc.2004.09.180","article-title":"Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells","volume":"324","author":"Qin","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0690","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nm1280","article-title":"Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque","volume":"11","author":"Li","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0695","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.antiviral.2006.10.008","article-title":"Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a\/7b, 3a\/3b and S","volume":"73","author":"Akerstr\u00f6m","year":"2007","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0700","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1111\/all.14850","article-title":"Silencing of SARS-CoV-2 with modified siRNA-peptide dendrimer formulation","volume":"76","author":"Khaitov","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0705","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.7150\/ijbs.59151","article-title":"Developing effective siRNAs to reduce the expression of key viral genes of COVID-19","volume":"17","author":"Wu","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0710","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/nar\/gkab1248","article-title":"Targeting genomic SARS-CoV-2 RNA with siRNAs allows efficient inhibition of viral replication and spread","volume":"50","author":"Ambike","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0715","doi-asserted-by":"crossref","first-page":"e202204556","DOI":"10.1002\/anie.202204556","article-title":"Suppression of SARS-CoV-2 replication with stabilized and click-chemistry modified siRNAs","volume":"61","author":"Traube","year":"2022","journal-title":"Angew. Chem. Int. Ed. Eng."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0720","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s42003-023-04589-5","article-title":"From a genome-wide screen of RNAi molecules against SARS-CoV-2 to a validated broad-spectrum and potent prophylaxis","volume":"6","author":"Yogev","year":"2023","journal-title":"Commun. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0725","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219523120","article-title":"Divalent siRNAs are bioavailable in the lung and efficiently block SARS-CoV-2 infection","volume":"120","author":"Hariharan","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2024","key":"10.1016\/j.ijbiomac.2025.145203_bb0730","article-title":"Virus-specific dicer-substrate siRNA swarms inhibit SARS-CoV-2 infection in TMPRSS2-expressing Vero E6 cells","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0735","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0740","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1080\/21645515.2020.1805992","article-title":"Prospects for mucosal vaccine: shutting the door on SARS-CoV-2","volume":"16","author":"Mudgal","year":"2020","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0745","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","article-title":"SARS and MERS: recent insights into emerging coronaviruses","volume":"14","author":"de Wit","year":"2016","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0750","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.7150\/ijbs.45134","article-title":"COVID-19: what has been learned and to be learned about the novel coronavirus disease","volume":"16","author":"Yi","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0755","doi-asserted-by":"crossref","DOI":"10.1128\/genomeA.00818-15","article-title":"Complete genome sequence of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) from the first imported MERS-CoV case in China","volume":"3","author":"Lu","year":"2015","journal-title":"Genome Announc."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0760","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1126\/science.1085952","article-title":"Characterization of a novel coronavirus associated with severe acute respiratory syndrome","volume":"300","author":"Rota","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0765","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.immuni.2020.04.016","article-title":"SARS-CoV-2: combating coronavirus emergence","volume":"52","author":"Graham","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0770","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/tbed.13707","article-title":"Stability of SARS-CoV-2 and other coronaviruses in the environment and on common touch surfaces and the influence of climatic conditions: a review","volume":"68","author":"Aboubakr","year":"2021","journal-title":"Transbound. Emerg. Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0775","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/v4113044","article-title":"Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies","volume":"4","author":"Geller","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0780","first-page":"86","article-title":"SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: future predictions","volume":"44","author":"Abdelghany","year":"2021","journal-title":"Biom. J."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0785","unstructured":"WHO, Tracking SARS-CoV-2 variants, (n.d.) 1\u201317. https:\/\/www.who.int\/en\/activities\/tracking-SARS-CoV-2-variants\/."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0790","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12967-020-02344-6","article-title":"Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant","volume":"18","author":"Pachetti","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0795","article-title":"Spike mutation pipeline reveals the emergence of a more transmissible form of SARS-CoV-2","author":"Korber","year":"2020","journal-title":"BioRxiv"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0800","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0805","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41591-020-0820-9","article-title":"The proximal origin of SARS-CoV-2","volume":"26","author":"Andersen","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0810","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bbrc.2020.10.102","article-title":"Evolution patterns of SARS-CoV-2: snapshot on its genome variants","volume":"538","author":"Giovanetti","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0815","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-97267-7","article-title":"Dynamics of SARS-CoV-2 mutations reveals regional-specificity and similar trends of N501 and high-frequency mutation N501Y in different levels of control measures","volume":"11","author":"Justo Arevalo","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0820","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s12276-021-00658-z","article-title":"Mutational spectrum of SARS-CoV-2 during the global pandemic","volume":"53","author":"Yi","year":"2021","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0825","doi-asserted-by":"crossref","DOI":"10.1093\/gbe\/evab087","article-title":"Mutation rates and selection on synonymous mutations in SARS-CoV-2","volume":"13","author":"De Maio","year":"2021","journal-title":"Genome Biol. Evol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0830","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0835","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2471\/BLT.20.253591","article-title":"Variant analysis of SARS-CoV-2 genomes","volume":"98","author":"Koyama","year":"2020","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0840","doi-asserted-by":"crossref","first-page":"e0240345","DOI":"10.1371\/journal.pone.0240345","article-title":"Large scale genomic analysis of 3067 SARS-CoV-2 genomes reveals a clonal geo-distribution and a rich genetic variations of hotspots mutations","volume":"15","author":"Laamarti","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0845","first-page":"671","article-title":"Identification of the hyper-variable genomic hotspot for the novel coronavirus SARS-CoV-2","volume":"80","author":"Wen","year":"2020","journal-title":"J. Inf. Secur."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0850","article-title":"Nanocarriers in glioblastoma treatment: a neuroimmunological perspective","author":"Firuzpour","year":"2024","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0855","doi-asserted-by":"crossref","first-page":"1112755","DOI":"10.3389\/fbioe.2023.1112755","article-title":"Potential of siRNA in COVID-19 therapy: emphasis on in silico design and nanoparticles based delivery","volume":"11","author":"Fopase","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0860","doi-asserted-by":"crossref","first-page":"102227","DOI":"10.1016\/j.omtn.2024.102227","article-title":"A novel multitargeted self-assembling peptide-siRNA complex for simultaneous inhibition of SARS-CoV-2-host cell interaction and replication","volume":"35","author":"Tuttolomondo","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0865","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/rr58","article-title":"The lung as a route for systemic delivery of therapeutic proteins and peptides","volume":"2","author":"Agu","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0870","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0014-5793(03)00209-6","article-title":"Gene silencing by adenovirus-delivered siRNA","volume":"539","author":"Shen","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0875","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/1043034041648462","article-title":"Adenovirus vector-mediated doxycycline-inducible RNA interference","volume":"15","author":"Hosono","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0880","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/cgt.2009.55","article-title":"Adenovirus-mediated transfer of siRNA against survivin enhances the radiosensitivity of human non-small cell lung cancer cells","volume":"17","author":"Yang","year":"2010","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0885","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.mito.2007.02.003","article-title":"Down-regulation of expression of rat pyruvate dehydrogenase E1alpha gene by self-complementary adeno-associated virus-mediated small interfering RNA delivery","volume":"7","author":"Han","year":"2007","journal-title":"Mitochondrion"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0890","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.gt.3302391","article-title":"Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference","volume":"12","author":"Sumimoto","year":"2005","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0895","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/gt.2008.15","article-title":"Small interfering RNA against interleukin-5 decreases airway eosinophilia and hyper-responsiveness","volume":"15","author":"Huang","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2011.02.006","article-title":"Pulmonary delivery of therapeutic siRNA","volume":"64","author":"Lam","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0905","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nbt1081","article-title":"Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA","volume":"23","author":"Judge","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0910","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1038\/nbt1038","article-title":"Lack of interferon response in animals to naked siRNAs","volume":"22","author":"Heidel","year":"2004","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0915","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/jir.2014.0034","article-title":"DsRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects","volume":"34","author":"Chattopadhyay","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0920","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nature06765","article-title":"Sequence- and target-independent angiogenesis suppression by siRNA via TLR3","volume":"452","author":"Kleinman","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0925","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0930","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1021\/ar200110p","article-title":"Nonviral pulmonary delivery of siRNA","volume":"45","author":"Merkel","year":"2012","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0935","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1872211309666150729122231","article-title":"Recent patents in pulmonary delivery of macromolecules","volume":"9","author":"Ray","year":"2015","journal-title":"Recent Pat. Drug Deliv. Formul."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0940","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2016.05.054","article-title":"Pulmonary administration of small interfering RNA: the route to go?","volume":"235","author":"Ruigrok","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0945","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0950","doi-asserted-by":"crossref","DOI":"10.3390\/molecules21091249","article-title":"Delivery of RNAi therapeutics to the airways-from bench to bedside","volume":"21","author":"Qiu","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0955","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.resp.2018.11.003","article-title":"Mice-to-men comparison of inhaled drug-aerosol deposition and clearance","volume":"260","author":"Kolanjiyil","year":"2019","journal-title":"Respir. Physiol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0960","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i4.20","article-title":"Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: relevance to humans","volume":"18","author":"Hickey","year":"2001","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0965","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/ng1173","article-title":"Induction of an interferon response by RNAi vectors in mammalian cells","volume":"34","author":"Bridge","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0970","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/ncb1038","article-title":"Activation of the interferon system by short-interfering RNAs","volume":"5","author":"Sledz","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0975","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.284.5418.1313","article-title":"Phylogenetic perspectives in innate immunity","volume":"284","author":"Hoffmann","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0980","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1126\/science.1183021","article-title":"Regulation of adaptive immunity by the innate immune system","volume":"327","author":"Iwasaki","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0985","doi-asserted-by":"crossref","first-page":"122713","DOI":"10.1016\/j.lfs.2024.122713","article-title":"Deciphering epigenetic regulations in the inflammatory pathways of atopic dermatitis","volume":"348","author":"da Silva Duarte","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0990","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.cell.2010.01.022","article-title":"Pattern recognition receptors and inflammation","volume":"140","author":"Takeuchi","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb0995","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.cell.2006.02.015","article-title":"Pathogen recognition and innate immunity","volume":"124","author":"Akira","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1000","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1005","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrendo.2009.62","article-title":"The role of interleukins in insulin resistance and type 2 diabetes mellitus","volume":"5","author":"F\u00e8ve","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1010","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nbt1205","article-title":"A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells","volume":"24","author":"Marques","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1015","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ymthe.2005.11.002","article-title":"Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo","volume":"13","author":"Judge","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1020","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/jgm.696","article-title":"Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis","volume":"7","author":"Akinc","year":"2005","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1025","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1089\/hum.2008.131","article-title":"Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation","volume":"19","author":"Robbins","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1030","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/bit.22312","article-title":"A novel high-throughput cell-based method for integrated quantification of type I interferons and in vitro screening of immunostimulatory RNA drug delivery","volume":"103","author":"Nguyen","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1035","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1038\/nbt1122","article-title":"Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs","volume":"23","author":"Morrissey","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1040","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/nbt.1564","article-title":"In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses","volume":"27","author":"Kortylewski","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413397","article-title":"Toll-like receptors (TLRs), NOD-like receptors (NLRs), and RIG-I-like receptors (RLRs) in innate immunity. TLRs, NLRs, and RLRs ligands as immunotherapeutic agents for hematopoietic diseases","volume":"22","author":"Wicherska-Paw\u0142owska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1050","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41419-023-05786-0","article-title":"Cathepsin B in programmed cell death machinery: mechanisms of execution and regulatory pathways","volume":"14","author":"Xie","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1055","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.00167","article-title":"Cathepsin B is required for NLRP3 inflammasome activation in macrophages, through NLRP3 interaction","volume":"8","author":"Chevriaux","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1060","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41419-019-1413-8","article-title":"Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1065","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1038\/cddis.2012.86","article-title":"Caspase-1: is IL-1 just the tip of the ICEberg?","volume":"3","author":"Denes","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1070","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1038\/ni1215-1292a","article-title":"Corrigendum: the receptor NLRP3 is a transcriptional regulator of TH2 differentiation","volume":"16","author":"Bruchard","year":"2015","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1075","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.molmed.2006.02.004","article-title":"Innate sensing of self and non-self RNAs by Toll-like receptors","volume":"12","author":"Sioud","year":"2006","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1090","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.addr.2007.03.006","article-title":"RNA interference and innate immunity","volume":"59","author":"Sioud","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1095","doi-asserted-by":"crossref","first-page":"10260","DOI":"10.1073\/pnas.0812956106","article-title":"Structural basis for the multiple interactions of the MyD88 TIR domain in TLR4 signaling","volume":"106","author":"Ohnishi","year":"2009","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/0022034510381264","article-title":"TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk","volume":"90","author":"Brown","year":"2011","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri3111","article-title":"The role of ubiquitylation in immune defence and pathogen evasion","volume":"12","author":"Jiang","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1110","first-page":"31","article-title":"Nuclear factor-kappaB: activation and regulation during Toll-like receptor signaling","volume":"4","author":"Carmody","year":"2007","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1115","doi-asserted-by":"crossref","first-page":"7806","DOI":"10.1128\/MCB.24.17.7806-7819.2004","article-title":"NF-kappaB and AP-1 connection: mechanism of NF-kappaB-dependent regulation of AP-1 activity","volume":"24","author":"Fujioka","year":"2004","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1120","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/all.15111","article-title":"Regulatory roles of three miRNAs on allergen mRNA expression in Tyrophagus putrescentiae","volume":"77","author":"Zhou","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1125","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.stem.2024.04.021","article-title":"Modified lentiviral globin gene therapy for pediatric \u03b2(0)\/\u03b2(0) transfusion-dependent \u03b2-thalassemia: a single-center, single-arm pilot trial","volume":"31","author":"Li","year":"2024","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1130","article-title":"Cytokine storm in COVID-19: immunopathogenesis and therapy","volume":"58","author":"Zanza","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1135","doi-asserted-by":"crossref","DOI":"10.3390\/ph13100294","article-title":"Overcoming barriers for siRNA therapeutics: from bench to bedside","volume":"13","author":"Sajid","year":"2020","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1140","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/mt.2010.39","article-title":"Designer lipids advance systemic siRNA delivery","volume":"18","author":"Liu","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1145","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.apsb.2021.08.009","article-title":"Pulmonary delivery of siRNA against acute lung injury\/acute respiratory distress syndrome","volume":"12","author":"Zoulikha","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.145203_bb1150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.14304\/SURYA.JPR.V4N7.5","article-title":"RNA therapeutics: RNAi and antisense mechanisms and clinical applications","volume":"4","author":"Chery","year":"2016","journal-title":"Postdoc J."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e30898","article-title":"Matrix metalloproteinase\/Fas ligand (MMP\/FasL) interaction dynamics in COVID-19: an in silico study and neuroimmune perspective","volume":"10","author":"Saleki","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1160","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.addr.2019.05.004","article-title":"Strategies, design, and chemistry in siRNA delivery systems","volume":"144","author":"Dong","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1165","doi-asserted-by":"crossref","first-page":"115052","DOI":"10.1016\/j.addr.2023.115052","article-title":"A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics","volume":"201","author":"Ranjbar","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1170","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/mt.2011.294","article-title":"Action and reaction: the biological response to siRNA and its delivery vehicles","volume":"20","author":"Kanasty","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1175","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1080\/15476286.2020.1868680","article-title":"Off-target effects of RNAi correlate with the mismatch rate between dsRNA and non-target mRNA","volume":"18","author":"Chen","year":"2021","journal-title":"RNA Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1180","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1093\/nar\/gkq341","article-title":"A screen of chemical modifications identifies position-specific modification by UNA to most potently reduce siRNA off-target effects","volume":"38","author":"Bramsen","year":"2010","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1185","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1471-2164-11-175","article-title":"Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis","volume":"11","author":"Sudbery","year":"2010","journal-title":"BMC Genomics"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1190","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.imlet.2011.10.001","article-title":"Impact of delivery systems on siRNA immune activation and RNA interference","volume":"141","author":"Forsbach","year":"2012","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1195","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/nar\/gkj439","article-title":"Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging","volume":"34","author":"Bartlett","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1200","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.cell.2009.01.035","article-title":"Origins and mechanisms of miRNAs and siRNAs","volume":"136","author":"Carthew","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26083456","article-title":"Recent update on siRNA therapeutics","volume":"26","author":"Ebenezer","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1210","doi-asserted-by":"crossref","first-page":"6020","DOI":"10.1093\/nar\/gkac456","article-title":"Considerations and recommendations for assessment of plasma protein binding and drug-drug interactions for siRNA therapeutics","volume":"50","author":"Humphreys","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1215","doi-asserted-by":"crossref","first-page":"1229393","DOI":"10.3389\/fcell.2023.1229393","article-title":"The regulation of lncRNAs and miRNAs in SARS-CoV-2 infection","volume":"11","author":"Lin","year":"2023","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1220","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/jmv.27734","article-title":"SARS-CoV-2, SARS-CoV, and MERS-CoV encode circular RNAs of spliceosome-independent origin","volume":"94","author":"Yang","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1225","doi-asserted-by":"crossref","first-page":"678994","DOI":"10.3389\/fgene.2021.678994","article-title":"Human microRNAs interacting with SARS-CoV-2 RNA sequences: computational analysis and experimental target validation","volume":"12","author":"Siniscalchi","year":"2021","journal-title":"Front. Genet."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1230","doi-asserted-by":"crossref","first-page":"149769","DOI":"10.1016\/j.bbrc.2024.149769","article-title":"Exploring the potential of structural modeling and molecular docking for efficient siRNA screening: a promising approach to combat viral mutants, with a focus on HIV-1","volume":"708","author":"Nematian","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1235","doi-asserted-by":"crossref","first-page":"21656","DOI":"10.1038\/s41598-023-48227-w","article-title":"Circulating miRNA profiles in COVID-19 patients and meta-analysis: implications for disease progression and prognosis","volume":"13","author":"Gao","year":"2023","journal-title":"Sci. Rep."},{"issue":"2021","key":"10.1016\/j.ijbiomac.2025.145203_bb1240","article-title":"Long noncoding RNAs as emerging regulators of COVID-19","volume":"12","author":"Yang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1245","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.omtn.2022.08.012","article-title":"New insights on circular RNAs and their potential applications as biomarkers, therapeutic agents, and preventive vaccines in viral infections: with a glance at SARS-CoV-2","volume":"29","author":"Rahmani-Kukia","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1250","doi-asserted-by":"crossref","first-page":"e0283589","DOI":"10.1371\/journal.pone.0283589","article-title":"Mapping CircRNA-miRNA-mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection","volume":"18","author":"Ayaz","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1255","doi-asserted-by":"crossref","first-page":"198956","DOI":"10.1016\/j.virusres.2022.198956","article-title":"Current understanding on long non-coding RNAs in immune response to COVID-19","volume":"323","author":"Ding","year":"2023","journal-title":"Virus Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1260","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.7150\/ijms.76168","article-title":"The emerging role of miRNAs in the pathogenesis of COVID-19: protective effects of nutraceutical polyphenolic compounds against SARS-CoV-2 infection","volume":"19","author":"Yang","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1265","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1210\/me.2013-1113","article-title":"Minireview: long noncoding RNAs: new \u201clinks\u201d between gene expression and cellular outcomes in endocrinology","volume":"27","author":"Sun","year":"2013","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1270","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles","volume":"313","author":"Lee","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1275","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1080\/15476286.2023.2272118","article-title":"Regulatory circular RNAs in viral diseases: applications in diagnosis and therapy","volume":"20","author":"Wang","year":"2023","journal-title":"RNA Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1280","doi-asserted-by":"crossref","first-page":"106024","DOI":"10.1016\/j.antiviral.2024.106024","article-title":"SiRNAs as antiviral drugs \u2014 current status, therapeutic potential and challenges","volume":"232","author":"Chokwassanasakulkit","year":"2024","journal-title":"Antivir. Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1285","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1016\/j.cell.2022.03.044","article-title":"Circular RNA vaccines against SARS-CoV-2 and emerging variants","volume":"185","author":"Qu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1290","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jiph.2022.06.012","article-title":"Micrornas in the development of potential therapeutic targets against COVID-19: a narrative review","volume":"15","author":"Ahmed","year":"2022","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1295","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2024.109846","article-title":"RNA editing in host lncRNAs as potential modulator in SARS-CoV-2 variants-host immune response dynamics","volume":"27","author":"Chattopadhyay","year":"2024","journal-title":"IScience"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1300","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1104\/pp.20.00293","article-title":"pssRNAit: a web server for designing effective and specific plant siRNAs with genome-wide off-target assessment","volume":"184","author":"Ahmed","year":"2020","journal-title":"Plant Physiol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1305","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nbt1404","article-title":"The impact of target site accessibility on the design of effective siRNAs","volume":"26","author":"Tafer","year":"2008","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1310","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1080\/15476286.2016.1229733","article-title":"SMEpred workbench: a web server for predicting efficacy of chemicallymodified siRNAs","volume":"13","author":"Dar","year":"2016","journal-title":"RNA Biol."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1315","doi-asserted-by":"crossref","first-page":"W130","DOI":"10.1093\/nar\/gkh366","article-title":"siRNA selection server: an automated siRNA oligonucleotide prediction server","volume":"32","author":"Yuan","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1320","doi-asserted-by":"crossref","first-page":"W104","DOI":"10.1093\/nar\/gkn250","article-title":"OligoWalk: an online siRNA design tool utilizing hybridization thermodynamics","volume":"36","author":"Lu","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1325","article-title":"Sound insulation property of threedimensional spacer fabric composites","author":"Cao","year":"2014","journal-title":"Fibres Text. East. Eur."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1330","series-title":"ASME Int. Mech. Eng. Congr. Expo","article-title":"Experimental investigation of thermal properties of hybrid glass fiber-sisal reinforced epoxy composites","author":"Palanikumar","year":"2015"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1335","article-title":"Sound-absorbing and thermal insulating properties of natural coir\/jute hybrid composites for functional materials","volume":"19","author":"Krishnasamy","year":"2024","journal-title":"J. Eng. Fibers Fabr."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1340","doi-asserted-by":"crossref","first-page":"11845","DOI":"10.1080\/15440478.2022.2044964","article-title":"Thermo-physical and fire properties of natural fiber composites for energy saving applications","volume":"19","author":"Kandula","year":"2022","journal-title":"J. Nat. Fibers"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1345","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.3390\/ma17235695","article-title":"Effect of natural fiber and biomass on acoustic performance of 3D hybrid fabric-reinforced composite panels","volume":"17","author":"Nazari","year":"2024","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1350","doi-asserted-by":"crossref","first-page":"2216S","DOI":"10.1177\/1528083721994677","article-title":"Development of hybrid layered structures based on natural fabric reinforced composites and warp knitted spacer fabric for acoustic applications","volume":"51","author":"Okur","year":"2022","journal-title":"J. Ind. Text."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1355","doi-asserted-by":"crossref","first-page":"138","DOI":"10.30723\/ijp.v14i31.181","article-title":"Preparation and studying of some properties of polymer composites reinforced with natural and artificial fibers","volume":"14","author":"Hameed","year":"2016","journal-title":"Iraqi J. Phys."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1360","first-page":"75","article-title":"Thermal and acoustic properties of natural fiber reinforced composites for automobile applications","volume":"2","author":"Li","year":"2009","journal-title":"J. Mater. Eng. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1365","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/aerospace5030075","article-title":"Sound absorption characterization of natural materials and sandwich structure composites","volume":"5","author":"Zhang","year":"2018","journal-title":"Aerospace"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1370","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1002\/pc.27633","article-title":"Recent progress in thermal and acoustic properties of natural fiber reinforced polymer composites: preparation, characterization, and data analysis","volume":"44","author":"Dev","year":"2023","journal-title":"Polym. Compos."},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1375","series-title":"Sound Absorption Properties of Polyurethane-based Warp-knitted Spacer Fabric Composites","author":"Chen","year":"2017"},{"key":"10.1016\/j.ijbiomac.2025.145203_bb1380","first-page":"18","article-title":"Investigation of sound absorption of warp knitted spacer fabric with nanofiber coating","volume":"10","author":"Davoudabadi Farahani","year":"2021","journal-title":"J. Text. Sci. Technol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025057563?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025057563?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,18]],"date-time":"2025-07-18T00:34:16Z","timestamp":1752798856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025057563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":276,"alternative-id":["S0141813025057563"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145203","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unveiling the translational and therapeutic potential of small interfering RNA molecules in combating SARS-CoV-2: A review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145203"}}